Interleukin-6 in psoriasis: expression and mitogenicity studies
dc.contributor.author | Benrazavi, S. | en_US |
dc.contributor.author | Pittelkow, M. R. | en_US |
dc.contributor.author | Boman, D. K. | en_US |
dc.contributor.author | Sartor, C. I. | en_US |
dc.contributor.author | Fisher, Gary J. | en_US |
dc.contributor.author | Elder, James T. | en_US |
dc.date.accessioned | 2006-09-11T18:45:25Z | |
dc.date.available | 2006-09-11T18:45:25Z | |
dc.date.issued | 1992-12 | en_US |
dc.identifier.citation | Elder, J. T.; Sartor, C. I.; Boman, D. K.; Benrazavi, S.; Fisher, G. J.; Pittelkow, M. R.; (1992). "Interleukin-6 in psoriasis: expression and mitogenicity studies." Archives of Dermatological Research 284(6): 324-332. <http://hdl.handle.net/2027.42/47246> | en_US |
dc.identifier.issn | 0340-3696 | en_US |
dc.identifier.issn | 1432-069X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/47246 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1294020&dopt=citation | en_US |
dc.description.abstract | InterIeukin-6 (IL-6) is a multifunctional cytokine which has been suggested to function as an autocrine mitogen in psoriatic epidermis. We report here the results of several experiments designed to further examine this hypothesis. Blot hybridization was unable to detect 1.3 kb IL-6 transcripts in RNA extracted from normal or psoriatic epidermal (keratome) biopsies, suggesting that IL-6 expression is very low in normal and psoriatic epidermis. Therefore, qualitative and semiquantitative PCR/Southern blot analyses were performed on keratome-derived RNA, and revealed variable but significantly increased IL-6 mRNA levels in lesional psoriatic relative to normal tissue. To further examine the ability of normal human keratinocytes (NHK) to express IL-6, RNA was extracted from rapidly proliferating secondary NHK cultures. IL-6 transcripts were nearly undetectable by blotting in keratinocytes grown in low-calcium serum-free medium, but low levels could be induced by treatment with 1.8 m M CaCl 2 . IL-6 transcripts were strongly superinduced after cycloheximide treatment, suggesting that a labile protein regulates IL-6 mRNA levels in these cells. Finally, the mitogenic activity of IL-6 was examined in NHK under varying conditions of cell density and added growth factors. IL-6 did not stimulate high density keratinocyte growth in the presence or absence of other growth factors, but did stimulate clonal growth in epidermal growth factor (EGF)-deficient media at high concentrations (≧10 ng/ml). The proliferative effects of IL-6, but not of basic fibroblast growth factor, were abrogated by monoclonal antibodies directed against the EGF receptor. Taken together, these results suggest that the proliferative effects of IL-6 are mediated indirectly via the EGF/TGF-α receptor, and that autocrine overexpression of IL-6 may be limited in psoriatic keratinocytes. | en_US |
dc.format.extent | 1850328 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Interleukin-6 | en_US |
dc.subject.other | Cell Proliferation | en_US |
dc.subject.other | Psoriasis | en_US |
dc.subject.other | Polymerase Chain Reaction | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Dermatology | en_US |
dc.subject.other | Keratinocytes | en_US |
dc.title | Interleukin-6 in psoriasis: expression and mitogenicity studies | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Dermatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan, Box 0672, 48109-0672, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Internal Mediaine, C560A MSRB II, University of Michigan, Box 0672, 48109-0672, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan, Box 0672, 48109-0672, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan, Box 0672, 48109-0672, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan, Box 0672, 48109-0672, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 1294020 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/47246/1/403_2004_Article_BF00372034.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00372034 | en_US |
dc.identifier.source | Archives of Dermatological Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.